NATERA, INC. Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
NATERA, INC. (NTRA) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost of $23.02 million as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis · last filed 2025-02-28
- 2024-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost $23.02M.
- 2024-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost $30.03M.
- 2024-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost $91.48M.
- 2024-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost $71.01M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost |
|---|---|
| 2024-12-31 | $23.02M 10-K · filed 2025-02-28 |
| 2024-09-30 | $30.03M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $91.48M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $71.01M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $239.61M 10-K · filed 2024-02-29 |
| 2023-09-30 | $272.98M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $363.70M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $420.36M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $448.40M 10-K · filed 2023-03-01 |
| 2022-09-30 | $483.40M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $563.54M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $607.43M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $832.18M 10-K · filed 2022-02-25 |
| 2021-09-30 | $927.10M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $514.99M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $585.25M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $684.35M 10-K · filed 2021-02-26 |
| 2020-09-30 | $595.05M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $488.08M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $326.04M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $378.14M 10-K · filed 2020-03-02 |
| 2019-09-30 | $185.84M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $207.26M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $94.07M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $108.01M 10-K · filed 2019-03-15 |
| 2018-09-30 | $131.78M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $71.76M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $80.93M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $107.01M 10-K · filed 2018-03-15 |
| 2017-09-30 | $135.41M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $95.45M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $107.22M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $131.59M 10-K · filed 2017-03-16 |
| 2016-09-30 | $157.38M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $206.54M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $204.47M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $208.97M 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |